Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo
Celia Fourrier, Emma Sampson, Natalie T Mills, Bernhard T Baune
Trials | BMC | Published : 2018
BACKGROUND: In patients with major depressive disorder (MDD), antidepressant response and remission rates are low, highlighting the need for new treatment approaches. Recently, the abundant literature linking inflammatory processes and depressive symptoms have led to the hypothesis that selecting treatment for MDD based on the patient's inflammatory status could be a promising strategy to improve outcomes in patients suffering from MDD. The aim of the randomised control trial we propose is to investigate the antidepressant efficacy of the combined treatment of MDD with antidepressant medication plus anti-inflammatory medication in individuals with raised inflammation levels. For the first ti..View full abstract
The presented work is supported by the Fay Fuller Foundation to BTB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.